Case Study: Boehringer Ingelheim speeds time-to-market and unifies R&D with Veeva Systems' Development Cloud

How Boehringer Ingelheim Deepened its Digital Transformation

Boehringer Ingelheim, a global biopharma company, faced a fragmented digital landscape where multiple best-of-breed systems didn’t interoperate, creating complex workflows, multiple logins and slower time-to-market for drugs. The challenge was to modernize R&D and trial operations while aligning digital initiatives with the company’s patient-centric culture and long-term strategy.

BI implemented a “One Medicine Platform” built on Veeva’s cloud solutions and deepened its internal digital capabilities through BI X incubators and in-house products. The integrated cloud approach reduced maintenance and interoperability burdens, improved collaboration with study sites, enabled faster data capture and analysis (supporting AI use), and accelerated drug development timelines while reinforcing a culture focused on patient outcomes.

Boehringer Ingelheim

Uli Broedl

Senior Vice President and Head of Global Clinical Development and Operations